Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01362491 · ClinicalTrials.gov registry record · Phase 3
Ibuprofen Sodium Tension Headache Study
A Phase 3 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 3
- Development phase
- 226
- Enrollment target
NCT01362491 is a Phase 3 study that has completed, run by Pfizer. The registered enrollment target is 226 participants.
The verdict
NCT01362491, a Phase 3 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 226 participants
- Enrollment target
Study Summary
This study will compare the ability of a single-dose of a novel ibuprofen formulation to relieve pain compared to placebo and standard ibuprofen in the treatment of tension-type headache
Interventions
- DRUG Placebo
- DRUG Ibuprofen Sodium
- DRUG Standard Ibuprofen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 226 participants |
| Start Date | 2011-06 |
| Est. Completion | 2012-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01362491
The ClinicalTrials.gov registry entry for NCT01362491 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 226 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01362491 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01362491 about?
NCT01362491 is a clinical study titled "Ibuprofen Sodium Tension Headache Study". This study will compare the ability of a single-dose of a novel ibuprofen formulation to relieve pain compared to placebo and standard ibuprofen in the treatment of tension-type headache
What is the current status of trial NCT01362491?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 226 participants. The study started on 2011-06. Estimated completion is 2012-03.
What interventions are being tested in trial NCT01362491?
The interventions under investigation include: Placebo (DRUG), Ibuprofen Sodium (DRUG), Standard Ibuprofen (DRUG).
Who is sponsoring clinical trial NCT01362491?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.